Research Articles
Antidiabetic effects of Aloe ferox and Aloe greatheadii var. davyana leaf gel extracts in a low-dose streptozotocin diabetes rat model
Submitted: 24 November 2010 | Published: 14 July 2011
About the author(s)
Du Toit Loots, Centre for Human Metabonomics, School for Physical and Chemical Sciences, North-West University, South AfricaMarlien Pieters, Centre of Excellence for Nutrition, North-West University, South Africa
Md Shahidul Islam, Centre of Excellence for Nutrition, North-West University, South Africa
Lisa Botes, Centre of Excellence for Nutrition, North-West University, South Africa
Abstract
Keywords
Metrics
Total abstract views: 1659Total article views: 2761
References
Vasudevan AR, Garber AJ. Insulin resistance syndrome. A review. Minerva Endocrinol. 2005;30:101–119.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Atlas. 2010;87:4–14.
Murugesh K, Yeligar V, Dash DK, Sengupta P, Maiti BC, Maity TK. Antidiabetic, antioxidant and antihyperlipidemic status of Heliotropium zeylanicum extract on streptozotocin-induced diabetes in rats. Biol Pharm Bull. 2006;29:2202–2205. doi:10.1248/bpb.29.2202
Ducorps M, Ndong W, Jupkwo B, et al. Diabetes in Cameroon. Classification difficulties in Africa. Médecine tropicale: revue du Corps de santé colon. 1996;56:264–270.
Agarwal OP. Prevention of atheromatous heart disease. Angiology. 1985;36:485–492. doi:10.1177/000331978503600801, PMid:2864002
Beppu HT, Nagamura Y, Fujita K. Hypoglycemic and antidiabetic effects in mice of Aloe arborescens Miller var. natalensis Berger. Phytother Res. 1993;7:S37–S42. doi:10.1002/ptr.2650070713
Rajasekaran S, Sivagnaman K, Subramanian S. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep. 2005;57:90–96. PMid:15849382
Elliot RB, Wasmuth H, Hill J, Songini M, Bottazzo GF, Sardinian IDDM Study Group. Diabetes and cow’s milk. Lancet. 1996;348(9042):1657.
Botes L, Van Der Westhuizen FH, Loots DT. Phytochemical content and antioxidant capacities of two Aloe greatheadii var. davyana extracts. Molecules. 2008;13:2169–2180. doi:10.3390/molecules13092169, PMid:18830148
Loots DT, Van Der Westhuizen FH, Botes L. Aloe ferox leaf gel phytochemical content, antioxidant capacity, and possible health benefits. J Agric Food Chem. 2007;55:6891–6896. doi:10.1021/jf071110t, PMid:17661490
Rajasekaran S, Sivagnaman K, Subramanian S. Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin. J Pharm Pharmacol. 2005;57:241–246. doi:10.1211/0022357055416, PMid:15720789
Szkudelski T. The mechanism of alloxan and streptozotocin action in b-cells of the rat pancreas. Physiol Res. 2001;50:536–546.
Portha B, Giroix MH, Kergoat M, Bailbe D, Blondel O, Serradas P. Animal models of non-insulin-dependent diabetes induced in the rat by experimental reduction of β cell mass. J Annu Diabetol Hotel Dieu. 1988:33–36.
Benzie IF, Strain JJ. Feric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15–27. doi:10.1016/S0076-6879(99)99005-5
Ellis SM, Steyn HS. Practical significance (effect sizes) versus or in combination with statistical significance (p-values). Manag Dyn. 2003;12:51–53.
Rosenthal R, Rosnow RL, Rubin DB. Contrasts and effect sizes in behavioural research: A correlational approach. Cambridge: Cambridge University Press; 2000.
Beppu HT, Koike K, Shimpo T, Chihara M, Hoshino CI, Kuzuya H. Radical-scavenging effects of Aloe arborescens Miller on prevention of pancreatic islet β-cell destruction in rats. J Ethnopharmacol. 2003;89:37–45. doi:10.1016/S0378-8741(03)00268-X
Islam MS, Loots DT. Experimental rodent models of type 2 diabetes: A review. Methods Find Exp Clin Pharmacol. 2009;31:249–261. doi:10.1358/mf.2009.31.4.1362513, PMid:19557203
Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005;54:1615–1625. doi:10.2337/diabetes.54.6.1615, PMid:15919781
Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 1997;26:143–146. doi:10.1002/hep.510260119, PMid:9214463
Brownlee M. A radical explanation for glucose-induced β cell dysfunction. J Clin Invest. 2003;112:1788–1790. doi:10.1172/JCI20501, PMid:14679173, PMid:297003
Burcelin R, Eddouks M, Maury J, Kande J, Assan R, Girard J. Excessive glucose production, rather than insulin resistance, accounts for hyperglycemia in recent-onset streptozotocin-diabetic rats. Diabetologia. 1995;38:283–290. doi:10.1007/BF00400632, PMid:7758874
Garcia-Compean D, Jaquez-Quintan JO, Maldonado-Gaza H. Hepatogenous diabetes. Current reviews of an ancient problem. Ann Hepatol. 2009;8:13–20. PMid:19221528
Satriano J, Vallon V. Primary kidney growth and its consequences at the onset of diabetes mellitus. Amino Acids. 2006;31:1–9. doi:10.1007/s00726-006-0326-x, PMid:16733619
Valentovic MA, Alejandro N, Carpenter B, Brown A, Ramos K. Streptozotocin (STZ) diabetes enhances benzo(alpha)pyrene induced renal injury in Sprague Dawley rats. Toxicol Lett. 2006;164:214–220. doi:10.1016/j.toxlet.2005.12.009, PMid:16460892
Lugman W, Abdella N, Moro M. Serum fructosamine concentration as measure of blood glucose control in insulin dependent diabetes. Br Med J. 1985;290:1075–1076. doi:10.1136/bmj.290.6474.1075-a, PMid:3921112 PMid:1418361
Jiao S, Matsuzawa Y, Matsubara K, et al. Increased activity of intestinal acyl-CoA:cholesterol acyltransferase in rats with streptozotocin-induced diabetes and restoration with insulin supplementation. Diabetes. 1988;37:342–346. doi:10.2337/diabetes.37.3.342, PMid:2967215
Kusunoki J, Aragane K, Kitamine T, et al. Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity. Arterioscler Thromb Vasc Biol. 2000;20:171–178. PMid:10634814
Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27:1496–1504. doi:10.2337/diacare.27.6.1496, PMid:15161808
Reader Comments
Before posting a comment, read our privacy policy.Post a comment (login required)
Crossref Citations
1. The Potential Therapeutic Value of Medicinal Plants in the Management of Metabolic Disorders
Trevor T. Nyakudya, Thulani Tshabalala, Rachael Dangarembizi, Kennedy H. Erlwanger, Ashwell R. Ndhlala
Molecules vol: 25 issue: 11 first page: 2669 year: 2020
doi: 10.3390/molecules25112669